Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Ascentage Pharma is discovering and developing small molecule drugs for the treatment of cancer that block or degrade protein targets implicated in cancer. It has active clinical programs targeting ...

Outsourcing to a contract development and manufacturing organization (CDMO) is a critical step for many biotech companies aiming to advance their programs without building costly internal ...